Regenerative medicine company PharmaResearch said on the 26th that it will sell half of its CTCBIO equity to Bionote. With this sale, PharmaResearch's CTCBIO stock equity ratio will decrease from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results